Muriel F.
- Country
- France
- Department
- Intensive Care
Research Overview
- Evaluation of Oseltamivir and Drug Combinations in Hospitalized Patients with Acute Respiratory Tract Infection: A Randomized Adaptive Platform Trial
- Evaluation of Recombinant Human Plasma Gelsolin in Moderate-to-Severe Acute Respiratory Distress Syndrome Due to Pneumonia or Other Infections
- Prognostic Impact of Early Low Plasma Oseltamivir Carboxylate Concentration in Critically Ill Adults with Severe Influenza in Intensive Care
Data & Insights
Has run more than one trial at 31 of 199 partner sites.
Specializations
Respiratory Infections
Specializes in investigating therapeutic approaches for community-acquired pneumonia and severe respiratory tract infections, including innovative treatment platforms for COVID-19 pneumonia. Focuses on evaluating immune modulation therapies and novel treatment combinations.
- Community-acquired pneumonia management
- COVID-19 pneumonia interventions
- Respiratory tract infection treatments
Critical Care Medicine
Conducts research in acute respiratory distress syndrome (ARDS) and severe influenza infections requiring intensive care intervention. Particular interest in emergency treatments for respiratory complications and critical care outcomes.
- ARDS treatment protocols
- Severe influenza management
- Emergency respiratory interventions
Specialized Conditions
Investigates treatments for sickle cell disease complications and hemoptysis. Focuses on innovative therapeutic approaches for immunocompromised patients with respiratory complications.
- Acute chest syndrome treatments
- Hemoptysis management
- Immunocompromised patient care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.